Biosynex Past Earnings Performance
Past criteria checks 0/6
Biosynex's earnings have been declining at an average annual rate of -2.7%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 21.6% per year.
Key information
-2.7%
Earnings growth rate
-2.8%
EPS growth rate
| Medical Equipment Industry Growth | 4.3% |
| Revenue growth rate | 21.6% |
| Return on equity | -29.9% |
| Net Margin | -39.7% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Biosynex makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 93 | -37 | 36 | 0 |
| 30 Sep 23 | 95 | -36 | 32 | 0 |
| 30 Jun 23 | 97 | -34 | 28 | 0 |
| 31 Mar 23 | 147 | -9 | 25 | 0 |
| 31 Dec 22 | 197 | 16 | 21 | 0 |
| 30 Sep 22 | 248 | 40 | 20 | 0 |
| 30 Jun 22 | 300 | 64 | 19 | 0 |
| 31 Mar 22 | 341 | 84 | 18 | 0 |
| 31 Dec 21 | 383 | 104 | 17 | 0 |
| 30 Sep 21 | 359 | 100 | 17 | 0 |
| 30 Jun 21 | 335 | 96 | 16 | 0 |
| 31 Mar 21 | 244 | 64 | 15 | 0 |
| 31 Dec 20 | 154 | 31 | 15 | 0 |
| 30 Sep 20 | 108 | 19 | 13 | 0 |
| 30 Jun 20 | 61 | 7 | 11 | 0 |
| 31 Mar 20 | 48 | 4 | 10 | 0 |
| 31 Dec 19 | 35 | 1 | 8 | 0 |
| 30 Sep 19 | 34 | 1 | 8 | 0 |
| 30 Jun 19 | 33 | 1 | 8 | 0 |
| 31 Mar 19 | 32 | 1 | 8 | 0 |
| 31 Dec 18 | 31 | 1 | 7 | 0 |
| 30 Sep 18 | 31 | 0 | 7 | 0 |
| 30 Jun 18 | 31 | 0 | 7 | 0 |
| 31 Mar 18 | 31 | 0 | 7 | 0 |
| 31 Dec 17 | 31 | 0 | 7 | 0 |
| 30 Sep 17 | 34 | 1 | 7 | 0 |
| 30 Jun 17 | 38 | 1 | 7 | 0 |
| 31 Mar 17 | 32 | 0 | 6 | 0 |
| 31 Dec 16 | 27 | 0 | 5 | 0 |
| 30 Sep 16 | 20 | -1 | 4 | 0 |
| 30 Jun 16 | 12 | -1 | 3 | 0 |
| 31 Mar 16 | 11 | -1 | 3 | 0 |
| 31 Dec 15 | 10 | 0 | 3 | 0 |
| 30 Sep 15 | 8 | 0 | 2 | 0 |
| 30 Jun 15 | 6 | 0 | 2 | 0 |
| 31 Mar 15 | 5 | -1 | 1 | 0 |
| 31 Dec 14 | 4 | -2 | 1 | 0 |
| 30 Sep 14 | 4 | -2 | 1 | 0 |
| 30 Jun 14 | 3 | -2 | 1 | 0 |
| 31 Mar 14 | 2 | -2 | 1 | 0 |
| 31 Dec 13 | 2 | -2 | 1 | 0 |
Quality Earnings: 0DL is currently unprofitable.
Growing Profit Margin: 0DL is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 0DL is unprofitable, and losses have increased over the past 5 years at a rate of 2.7% per year.
Accelerating Growth: Unable to compare 0DL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 0DL is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (16.2%).
Return on Equity
High ROE: 0DL has a negative Return on Equity (-29.86%), as it is currently unprofitable.